Teleflex Incorporated $TFX Shares Purchased by Tejara Capital Ltd

Tejara Capital Ltd boosted its stake in Teleflex Incorporated (NYSE:TFX) by 871.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 77,700 shares of the medical technology company’s stock after buying an additional 69,700 shares during the quarter. Teleflex makes up approximately 2.2% of Tejara Capital Ltd’s portfolio, making the stock its 6th largest holding. Tejara Capital Ltd’s holdings in Teleflex were worth $9,483,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Thrivent Financial for Lutherans increased its position in shares of Teleflex by 40.6% during the fourth quarter. Thrivent Financial for Lutherans now owns 774,034 shares of the medical technology company’s stock worth $94,463,000 after purchasing an additional 223,585 shares in the last quarter. Baader Bank Aktiengesellschaft lifted its holdings in Teleflex by 32.4% in the 4th quarter. Baader Bank Aktiengesellschaft now owns 43,333 shares of the medical technology company’s stock valued at $5,288,000 after purchasing an additional 10,600 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its stake in Teleflex by 1.7% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,114 shares of the medical technology company’s stock worth $1,234,000 after purchasing an additional 167 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al grew its holdings in shares of Teleflex by 17.8% during the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 10,600 shares of the medical technology company’s stock worth $1,294,000 after buying an additional 1,600 shares in the last quarter. Finally, First Eagle Investment Management LLC grew its holdings in shares of Teleflex by 163.4% during the fourth quarter. First Eagle Investment Management LLC now owns 84,300 shares of the medical technology company’s stock worth $10,288,000 after buying an additional 52,300 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Truist Financial reiterated a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Raymond James Financial restated an “outperform” rating and set a $150.00 target price on shares of Teleflex in a report on Friday, May 8th. Finally, Wells Fargo & Company upped their price target on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $144.00.

Teleflex Trading Up 0.3%

Shares of TFX stock opened at $130.42 on Friday. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $139.67. The company’s 50-day moving average price is $120.53 and its 200-day moving average price is $116.68. The stock has a market cap of $5.77 billion, a price-to-earnings ratio of -5.72, a PEG ratio of 0.97 and a beta of 0.82.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same period last year, the business earned $1.44 earnings per share. Teleflex’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Key Stories Impacting Teleflex

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Teleflex beat first-quarter earnings and revenue expectations, which signals that near-term business performance is still holding up better than expected, even as the market digests margin pressure. TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash
• Positive Sentiment: Needham & Company reiterated a Buy rating and a $147 price target, suggesting confidence that Teleflex can deliver meaningful earnings growth over the next several years.
• Positive Sentiment: The company’s latest earnings outlook still implies growth from the current year to FY2027 and FY2028, which may help support investor sentiment despite the recent reset in estimates.
• Neutral Sentiment: Analysts at Citizens JMP and Needham released mostly constructive but varied quarterly projections for FY2026 and FY2027, indicating that expectations remain in flux following the earnings report.
• Negative Sentiment: Wolfe Research lowered Teleflex’s FY2026, FY2027, FY2028, FY2029 and FY2030 EPS estimates, reflecting a more cautious view on the company’s longer-term earnings trajectory.
• Negative Sentiment: The post-earnings reaction was hurt by steep margin declines and a 52.1% drop in operating profit, which raised concerns that revenue growth is not yet translating into strong profitability. TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.